Bone plate
Latest Bristol-Myers Squibb Company Patents:
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
- Substituted bicyclic compounds useful as T cell activators
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Description
FIG. 1 is a perspective view of a bone plate showing our new design.
FIG. 2 is a top elevational view thereof.
FIG. 3 is a bottom elevational view thereof.
FIG. 4 is a front elevational view thereof.
FIG. 5 is a back elevational view thereof.
FIGS. 6 and 7 are end elevational views thereof taken from opposing ends of a bone plate showing our new design.
Claims
The ornamental design for a bone plate, as shown.
Referenced Cited
Patent History
Patent number: D443060
Type: Grant
Filed: Jun 1, 2000
Date of Patent: May 29, 2001
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Steve Benirschke (Seattle, WA), Mark Bryant (Auburn, IN), Paul Duwelius (Lake Oswego, OR), James Goulet (Ann Arbor, MI), Patrick Rousseau (Hardwick, NJ), David Templeman (Plymouth, MN), Robert A. Winquist (Seattle, WA)
Primary Examiner: Antoine Duval Davis
Attorney, Agent or Law Firm: Baker & Daniels
Application Number: 29/124,202
Type: Grant
Filed: Jun 1, 2000
Date of Patent: May 29, 2001
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Steve Benirschke (Seattle, WA), Mark Bryant (Auburn, IN), Paul Duwelius (Lake Oswego, OR), James Goulet (Ann Arbor, MI), Patrick Rousseau (Hardwick, NJ), David Templeman (Plymouth, MN), Robert A. Winquist (Seattle, WA)
Primary Examiner: Antoine Duval Davis
Attorney, Agent or Law Firm: Baker & Daniels
Application Number: 29/124,202
Classifications
